Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) — Financial Flexibility Index
Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) has a Financial Flexibility Index of -0.82x as of September 2025. Free cash flow of $-4.45 Million (operating CF $-4.51 Million minus capex $60.38K) represents -1% of total liabilities ($5.43 Million). Also explore Eupraxia Pharmaceuticals Inc. Common Sto (EPRX) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eupraxia Pharmaceuticals Inc. Common Stock Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Eupraxia Pharmaceuticals Inc. Common Stock across 8 annual periods. Check Eupraxia Pharmaceuticals Inc. Common Sto (EPRX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Eupraxia Pharmaceuticals Inc. Common Stock (2017–2024)
Year-by-year free cash flow to debt coverage for Eupraxia Pharmaceuticals Inc. Common Stock. For the full company profile including market capitalisation, see how much is Eupraxia Pharmaceuticals Inc. Common Sto worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -9.63x | $-29.89 Million | $-29.99 Million | $3.10 Million | ▼ -802.5% |
| 2023 | -1.07x | $-20.68 Million | $-20.75 Million | $19.37 Million | ▼ -21.6% |
| 2022 | -0.88x | $-14.16 Million | $-14.40 Million | $16.13 Million | ▲ +5.4% |
| 2021 | -0.93x | $-11.23 Million | $-11.58 Million | $12.10 Million | ▼ -5213.8% |
| 2020 | -0.02x | $-403.78K | $-403.78K | $23.12 Million | ▲ +92.8% |
| 2019 | -0.24x | $-5.16 Million | $-5.17 Million | $21.42 Million | ▲ +57.7% |
| 2018 | -0.57x | $-8.18 Million | $-8.32 Million | $14.34 Million | ▲ +91.6% |
| 2017 | -6.77x | $-4.98 Million | $-5.30 Million | $735.82K | — |